Health ❯ Healthcare ❯ Research Studies

Phase 3 Trials

Sotagliflozin HERIZON-GEA-01 VALOR Trial SURMOUNT-5 Study KEYNOTE-937 Efficacy Comparisons Efficacy and Safety ASCENT-07 Study HI-PEITHO Trial IGNYTE-3 Trial MajesTEC-9 Study ESSENCE Trial

NEJM Publication Confirms Phase 3 Win for Brepocitinib in Dermatomyositis

The FDA is conducting a Priority Review with a decision expected in the third quarter of 2026.

HI-PEITHO Finds Catheter Ultrasound Thrombolysis Halves 30-Day Events in Intermediate-Risk PE

Tecvayli Cuts Progression Risk 71% and Deaths 40% in Phase 3 Myeloma Trial

Sacituzumab Govitecan Gains First-Line Ground in TNBC, Falls Short in Early HR+/HER2− Use

Replimune Reports No Defined Accelerated-Approval Path After FDA Type A Meeting on RP1 for Melanoma